Use of combinations of trimethoprim and sulphamethoxazole in the treatment of chest infections.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013183:Sputum / Q000378:metabolism / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D000667:Ampicillin; D014295:Trimethoprim; D013420:Sulfamethoxazole